Schoenberg Mark sold URGN
June 8, 2026 · Form 4 insider transaction
Schoenberg Mark sold 5,222 shares of UroGen Pharma Ltd. at $27.30 per share, a transaction worth $142.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
5,222
Price
$27.30
Total value
$142.6K
InsiderSchoenberg Mark
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateJune 8, 2026
Filing dateJune 9, 2026
Shares owned after139,763
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.